19 Recruiting Melanoma Clinical Trials in California
Explore active melanoma research studies enrolling across California. Verify eligibility and contact site coordinators.
📍 Find Near Me by DistanceRecruiting Melanoma Studies in California
Randomized Study Comparing Two Dosing Schedules for Hypofractionated Image-Guided Radiation Therapy
📍 University of California San Francisco — San Francisco, California
View Study & Checklist ➔A Study to Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3
📍 UC San Diego Moores Cancer Center — La Jolla, California
View Study & Checklist ➔Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients
📍 Saint John's Health Center - John Wayne Cancer Institute (JWCI) — Santa Monica, California
View Study & Checklist ➔A Phase II Study of the Interleukin-6 Receptor Inhibitor Tocilizumab in Combination With Ipilimumab and Nivolumab in Patients With Unresectable Stage III or Stage IV Melanoma
📍 The Angeles Clinic — Los Angeles, California
View Study & Checklist ➔A Study to Assess IPN01194 When Administered Alone in Adults With Advanced Solid Tumours
📍 The Angeles Clinic and Research Institute - California — Los Angeles, California
View Study & Checklist ➔A Study to Evaluate the Safety and Activity of Belvarafenib as a Single Agent and in Combination With Either Cobimetinib or Cobimetinib Plus Nivolumab in Patients With NRAS-mutant Advanced Melanoma.
📍 California Pacific Medical Center Research Institute — San Francisco, California
View Study & Checklist ➔Study of Efficacy and Safety of LXH254 Combinations in Patients With Previously Treated Unresectable or Metastatic Melanoma
📍 The Angeles Clinic and Research Institute — Los Angeles, California
View Study & Checklist ➔A Study of IBI363 in Subjects with Advanced Solid Malignancies
📍 University of California, San Francisco (UCSF) — San Francisco, California
View Study & Checklist ➔Clinical Study of Fianlimab in Combination With Cemiplimab Versus Pembrolizumab in Adolescent and Adult Patients With Previously Untreated Unresectable Locally Advanced or Metastatic Melanoma
📍 UC San Diego — La Jolla, California
View Study & Checklist ➔A Trial to See if the Combination of Fianlimab With Cemiplimab Works Better Than Pembrolizumab for Preventing or Delaying Melanoma From Coming Back After it Has Been Removed With Surgery
📍 UC San Diego — La Jolla, California
View Study & Checklist ➔A Study to Evaluate ABP 206 Compared With OPDIVO® (Nivolumab) in Subjects With Unresectable or Metastatic Melanoma
📍 Cancer and Blood Specialty clinic — Long Beach, California
View Study & Checklist ➔A Trial to Learn if Fianlimab and Cemiplimab Are Safe and Work Better Than Anti-PD1 Alone in Adult Participants With Resectable Stage 3 or 4 Melanoma
📍 UC San Diego — La Jolla, California
View Study & Checklist ➔A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer
📍 GSK Investigational Site — Los Angeles, California
View Study & Checklist ➔A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body
📍 USC Norris Comprehensive Cancer Center — Los Angeles, California
View Study & Checklist ➔Trial of Relatlimab, Nivolumab, and Ipilimumab in Patients With Asymptomatic and Symptomatic Melanoma Brain Metastases
📍 Stanford University — Palo Alto, California
View Study & Checklist ➔Metronomic Cyclophosphamide With Pembrolizumab in Checkpoint Inhibitor Refractory Melanoma
📍 Chao Family Comprehensive Cancer Center University of California, Irvine — Orange, California
View Study & Checklist ➔Interleukin-6 Receptor Inhibitor Sarilumab in Combination With Ipilimumab, Nivolumab and Relatlimab in Patients With Unresectable Stage III or Stage IV Melanoma
📍 The Angeles Clinic at Cedars Sinai — Los Angeles, California
View Study & Checklist ➔A Study of Ceralasertib Monotherapy and Ceralasertib Plus Durvalumab in Patients With Melanoma and Resistance to PD-(L)1 Inhibition
📍 Research Site — Los Angeles, California
View Study & Checklist ➔Community Based Strategies for Early Detection of Melanoma
📍 Clinica Romero — Los Angeles, California
View Study & Checklist ➔